Showing items 1–100
Methods and compositions for inhibiting PMP22 expression
Grant US-11959080-B2
United States of America
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene…
Grant US-11952573-B2
United States of America
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
Grant US-11926832-B2
United States of America
Compounds and methods for reducing ATXN2 expression
Grant US-11926825-B2
United States of America
Negative regulator AtRTP5 and use thereof in plant resistance to Phytophthora
Grant US-11920142-B2
United States of America
Branched oligonucleotides
Grant US-11896669-B2
United States of America
Lipid formulated compositions and methods for inhibiting expression of serum amyloid a…
Grant US-11884919-B2
United States of America
Compositions and methods for producing tobacco plants and products having reduced or…
Grant US-11879130-B2
United States of America
Compounds and methods for reducing LRRK2 expression
Grant US-11873495-B2
United States of America
Complement component C5 iRNA compositions and methods of use thereof
Grant US-11873491-B2
United States of America
Allosteric conditional guide RNAs for cell-selective regulation of CRISPR/Cas
Grant US-11873485-B2
United States of America
Complement component C3 iRNA compositions and methods of use thereof
Grant US-11866701-B2
United States of America
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7…
Grant US-11865134-B2
United States of America
Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof
Grant US-11866710-B2
United States of America
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant US-11866709-B2
United States of America
Glucokinase (GCK) iRNA compositions and methods of use thereof
Grant US-11859185-B2
United States of America
Antisense oligonucleotide compositions
Grant US-11859180-B2
United States of America
Compositions and methods for modulating apolipoprotein (a) expression
Grant US-11851655-B2
United States of America
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
Grant US-11845989-B2
United States of America
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant US-11840692-B2
United States of America
Modulation of prekallikrein (PKK) expression
Grant US-11840686-B2
United States of America
Compounds and methods for increasing STMN2 expression
Grant US-11833168-B2
United States of America
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant US-11834662-B2
United States of America
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant US-11834661-B2
United States of America
Compositions for modulating Ataxin 2 expression
Grant US-11834660-B2
United States of America
Oligomeric compounds for reducing DMPK expression
Grant US-11833221-B2
United States of America
Pale yellow locus and its applications in tobacco
Grant US-11827893-B2
United States of America
Double-helix oligonucleotide construct comprising double-stranded miRNA and use thereof
Grant US-11820984-B2
United States of America
Polynucleotide molecules for gene regulation in plants
Grant US-11812738-B2
United States of America
Mutant polymerases and uses thereof
Grant US-11814655-B2
United States of America
Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
Grant US-11806360-B2
United States of America
Compositions and methods for producing tobacco plants and products having reduced or…
Grant US-11807860-B2
United States of America
Methods and compositions for delivering nucleic acids to plant cells and regulating gene…
Grant US-11807857-B2
United States of America
Methods of making fucosylated and afucosylated forms of a protein
Grant US-11802165-B2
United States of America
Compounds and methods for modulating GFAP
Grant US-11786546-B2
United States of America
Methods for treating Alzheimer's disease
Grant US-11781135-B2
United States of America
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
Grant US-11767526-B2
United States of America
Small molecule regulators of mitochondrial fusion and methods of use thereof
Grant US-11760733-B2
United States of America
Compounds and methods for reducing IFNAR1 expression
Grant US-11753644-B2
United States of America
Allele specific modulators of P23H rhodopsin
Grant US-11744846-B2
United States of America
Compounds and methods for modulating PLP1
Grant US-11732263-B2
United States of America
Selective antisense compounds and uses thereof
Grant US-11732261-B2
United States of America
Compositions and methods for modulating complement factor B expression
Grant US-11732265-B2
United States of America
Use of FUBP1 inhibitors for treating hepatitis B virus infection
Grant US-11732262-B2
United States of America
Compounds and methods for the modulation of amyloid-β precursor protein
Grant US-11732260-B2
United States of America
Serpina1 iRNA compositions and methods of use thereof
Grant US-11725207-B2
United States of America
TMPRSS6 iRNA compositions and methods of use thereof
Grant US-11725209-B2
United States of America
TRPC3 as a therapeutic target for alzheimer's disease
Grant US-11723347-B2
United States of America
Modulation of GYS1 expression
Grant US-11713462-B2
United States of America
Modified gene silencing
Grant US-11708577-B2
United States of America
Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other…
Grant US-11702659-B2
United States of America
Detection and treatment of neurological diseases
Grant US-11686725-B2
United States of America
Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stra…
Grant US-11667918-B2
United States of America
Methods and compositions for modulating apolipoprotein (a) expression
Grant US-11634711-B2
United States of America
Compositions and methods for modulating PKK expression
Grant US-11613752-B2
United States of America
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant US-11613751-B2
United States of America
Methods and compositions related to improved nitrogen utilization efficiency in tobacco
Grant US-11602118-B2
United States of America
Activation of natural cytotoxicity receptor 2 (NCR2)
Grant US-11596655-B2
United States of America
Compositions for modulating Tau expression
Grant US-11591595-B2
United States of America
Expression of Fc-containing proteins
Grant US-11591382-B2
United States of America
RNAi agents for hepatitis B virus infection
Grant US-11590156-B2
United States of America
Compounds and methods for reducing ATXN3 expression
Grant US-11583548-B2
United States of America
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
Grant US-11566245-B2
United States of America
COMPOSITION FOR DELIVERY OF GENETIC MATERIAL
Application EP-4122498-A1
European Patent Office
AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
Application EP-4119668-A1
European Patent Office
Modulators of FOXP3 expression
Grant US-11547718-B2
United States of America
Compounds and methods for modulating ATXN1
Grant US-11542504-B2
United States of America
Modulation of transthyretin expression
Grant US-11535849-B2
United States of America
RNAi therapy for hepatitis B virus infection
Grant US-11534453-B2
United States of America
Compositions and methods for modulation of SMN2 splicing in a subject
Grant US-11535848-B2
United States of America
Methods for treating hypercholesterolemia
Grant US-11530410-B2
United States of America
Methods for reducing LRRK2 expression
Grant US-11530411-B2
United States of America
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant US-11525138-B2
United States of America
RNAi agents for Hepatitis B virus infection
Grant US-11517584-B2
United States of America
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
Grant US-11512309-B2
United States of America
ANTIBODY-PROTAMINE FUSIONS AS TARGETING COMPOUNDS OF A PROTAMINE-BASED NANOPARTICLE
Application WO-2022243518-A1
World Intellectual Property Organisation (WIPO)
Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof
Grant US-11492623-B2
United States of America
Compositions and methods for improving crop yields through trait stacking
Grant US-11472852-B2
United States of America
Methods and compositions for controlling efficacy of RNA silencing
Grant US-11459562-B2
United States of America
Modulation of frataxin expression
Grant US-11459564-B2
United States of America
Compounds and methods for modulating angiotensinogen expression
Grant US-11447521-B2
United States of America
Compositions and methods for producing tobacco plants and products having reduced or…
Grant US-11447790-B2
United States of America
Compositions and methods for improving crop yields through trait stacking
Grant US-11441153-B2
United States of America
Compounds and methods for reducing ATXN3 expression
Grant US-11434488-B2
United States of America
Targeted compositions
Grant US-11427823-B2
United States of America
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant US-11419942-B2
United States of America
Modulation of Huntington expression
Grant US-11421231-B2
United States of America
Methods and compositions for short stature plants through manipulation of gibberellin…
Grant US-11414670-B2
United States of America
Aminoalcohol lipidoids and uses thereof
Grant US-11414393-B2
United States of America
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant US-11408001-B1
United States of America
Method of conjugating oligomeric compounds
Grant US-11400161-B2
United States of America
Compositions and methods for controlling Leptinotarsa
Grant US-11377667-B2
United States of America
Modulation of factor 11 expression
Grant US-11376273-B2
United States of America
Modulators of EZH2 expression
Grant US-11365416-B2
United States of America
ELECTROSTATIC NANOPARTICLES AND USE THEREOF
Application WO-2022117731-A1
World Intellectual Property Organisation (WIPO)
Compositions for modulating C9ORF72 expression
Grant US-11339393-B2
United States of America
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene…
Grant US-11332745-B2
United States of America
Compounds and methods for reducing LRRK2 expression
Grant US-11332746-B1
United States of America
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant US-11332743-B2
United States of America
Showing items 1–100